Journal article
“Part of the Ritual”: Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome
Abstract
BACKGROUND: Antiphospholipid syndrome is associated with recurrent pregnancy loss. Low-molecular-weight heparin (LMWH) and/or aspirin (ASA) prophylaxis during pregnancy to prevent future loss is based on limited trial data with mixed results.
OBJECTIVES: Given the clinical equipoise, we sought to understand how patients and physicians navigate the decision-making process for use of LMWH and/or ASA in pregnancy.
Authors
Skeith L; Rodger M; Bates S; Gonsalves C; Karovitch A; Taylor T
Journal
Thrombosis and Haemostasis, Vol. 121, No. 10, pp. 1353–1360
Publisher
Thieme
Publication Date
October 2021
DOI
10.1055/a-1366-9261
ISSN
0340-6245
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Abortion, SpontaneousAnticoagulantsAntiphospholipid SyndromeAspirinAttitude of Health PersonnelChoice BehaviorClinical Decision-MakingDecision Making, SharedFemaleFibrinolytic AgentsHealth Knowledge, Attitudes, PracticeHeparin, Low-Molecular-WeightHumansInterviews as TopicPatient ParticipationPatient SafetyPregnancyPregnancy Complications, HematologicQualitative ResearchRisk AssessmentRisk FactorsTherapeutic EquipoiseThrombosis